129 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
to have access to Confidential Information. The Executive will receive and hold all Confidential Information on the terms and conditions set out … had and will continue to have a senior executive role for the Company, has had and will continue to have extensive access to, and has been
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
19 Jan 24
Regulation FD Disclosure
2:33pm
Chat Series on January 25, 2024, at 1:00 pm ET.
This event is open access for all investors. Topics will include:
An overview of InMed’s pharmaceutical
424B3
v2tixmrurdbn zwk6a7o
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-10.1
x83llfnl
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
vh0caeslds0j7j20
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
DEFA14A
cexo024
27 Oct 23
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
c37g q9uesk04egzet8x
25 Sep 23
Other Events
4:12pm
8-K
EX-99.1
hhxc1vq0
24 Jul 23
Regulation FD Disclosure
4:26pm
8-K
EX-99.1
m82x1ki4ptm53azz4
19 May 23
Regulation FD Disclosure
1:41pm
424B3
tep4p34pph fd4dmcy2j
15 Dec 22
Prospectus supplement
11:42am
8-K
ii0fx05lea
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
4:01pm
8-K
EX-99.1
21j42h
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
4:01pm
8-K
EX-10.2
ikjq50mva1fqr4 otvfg
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm